Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Alaunos Therapeutics, Inc. (TCRT) had Current Assets of $1.07M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$0.00M |
|
$-1.07M |
|
-- |
|
$0.00M |
|
$1.09M |
|
$-1.09M |
|
$0.02M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.09M |
|
$-1.09M |
|
1.60M |
|
1.60M |
|
$-0.67 |
|
$-0.67 |
|
Balance Sheet Financials | |
Current Assets |
$1.07M |
-- |
|
$1.05M |
|
$2.12M |
|
$1.06M |
|
-- |
|
-- |
|
$1.06M |
|
$1.06M |
|
$1.06M |
|
$1.06M |
|
1.60M |
|
Cash Flow Statement Financials | |
$-0.77M |
|
$0.00M |
|
$0.00M |
|
$1.09M |
|
$0.32M |
|
$-0.77M |
|
$0.07M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-54600.00% |
|
-54600.00% |
|
-- |
|
-53649.99% |
|
-53649.99% |
|
$-0.77M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.00 |
|
90.00 |
|
-101.41% |
|
-101.42% |
|
-50.61% |
|
-101.42% |
|
$0.66 |
|
$-0.48 |
|
$-0.48 |